Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 17

Results For "therapies"

1514 News Found

Symeres and Ambagon team up to target ‘undruggable’ proteins in colorectal cancer
News | April 07, 2026

Symeres and Ambagon team up to target ‘undruggable’ proteins in colorectal cancer

Under the collaboration, Symeres will test Ambagon’s newly designed molecular glues using in vitro assays and mechanistic studies


HRV Pharma, Shodhana join hands to build next-gen API pipeline for global markets
News | April 07, 2026

HRV Pharma, Shodhana join hands to build next-gen API pipeline for global markets

Multi-year CDMO partnership combines AI-led virtual development, precision chemistry and GMP manufacturing to accelerate five high-science APIs across regulated markets


Thyrocare’s Bharat Aarogyam score flags silent health risks in 9 out of 10 Indians
Healthcare | April 07, 2026

Thyrocare’s Bharat Aarogyam score flags silent health risks in 9 out of 10 Indians

Analysis of over 93 lakh preventive health checkups reveals disease risks emerging as early as the 20s


Red Nucleus acquires Bridge Medical Consulting with advisory support from VERTICES PARTNERS
News | April 06, 2026

Red Nucleus acquires Bridge Medical Consulting with advisory support from VERTICES PARTNERS

As part of the deal, Red Nucleus also gains indirect ownership of the company’s Indian arm


Samsung Biologics lands first US manufacturing facility with GSK acquisition
News | April 06, 2026

Samsung Biologics lands first US manufacturing facility with GSK acquisition

Samsung Biologics will continue supplying products previously manufactured at the site to GSK


Enveric Biosciences bags key US patent for mental health drug
Biotech | April 06, 2026

Enveric Biosciences bags key US patent for mental health drug

EB-003 is Enveric’s lead neuroplastogen, a 5-HT2A / 5-HT1B dual-acting compound designed to promote neuroplastic changes


Enveda’s experimental oral therapy shows breakthrough results in atopic dermatitis trial
Biotech | April 06, 2026

Enveda’s experimental oral therapy shows breakthrough results in atopic dermatitis trial

Safety was equally impressive. ENV-294 was well tolerated


Sanofi appoints Dr Parikshit Chaudhari as Head of Market Access & Pricing Strategy
People | April 06, 2026

Sanofi appoints Dr Parikshit Chaudhari as Head of Market Access & Pricing Strategy

He brings extensive cross-functional expertise built through leadership roles


Experts advocate holistic Semaglutide use as therapy goes off patent in India
Healthcare | April 06, 2026

Experts advocate holistic Semaglutide use as therapy goes off patent in India

They also differentiated the innovator biologic Semaglutide molecule from newer synthetic or chemical generic versions entering the market


Dr Jitendra Singh calls for India-led biosimilar insulin scale-up amid global supply concerns
Biotech | April 05, 2026

Dr Jitendra Singh calls for India-led biosimilar insulin scale-up amid global supply concerns

Minister highlights scope for domestic manufacturing during his meeting with Dr Niti Pall, President-elect, International Diabetes Federation